5711 - 5720 of 8785 Results
Title
Year
-
RESTRICTEDTitle: A Ranking-based Weakly Supervised Learning model for telemonitoring of Parkinson’s diseaseJournal Name: IISE Transactions on Healthcare Systems EngineeringPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 322End Page: 336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/24725579.2022.2091065Citation Count: 3
-
OPENTitle: Identification of risk factors for impulse-control disorder symptoms in patients with Parkinson’s diseaseJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012099End Page: 012099Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012099Best OA location URL: https://doi.org/10.1088/1742-6596/1722/1/012099Citation Count: 1
-
OPENTitle: Analysis of factors associated with early stage Parkinson’s disease based on daily activities and sleeping behaviour disorderJournal Name: Journal of Physics: Conference SeriesPublisher: IOP PublishingVol: 1722Issue #: 1Start Page: 012045End Page: 012045Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1742-6596/1722/1/012045Best OA location URL: https://doi.org/10.1088/1742-6596/1722/1/012045Citation Count: 1
-
OPENTitle: NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 12Start Page: 3692End Page: 3709Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab214Best OA location URL: https://academic.oup.com/brain/article-pdf/144/12/3692/42004679/awab214.pdfCitation Count: 15
-
RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xCitation Count: 103
-
RESTRICTEDTitle: Aducanumab: look before leapingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 9Start Page: 1499End Page: 1499Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01477-5Citation Count: 11
-
OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 67
-
RESTRICTEDTitle: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarkerJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 29Issue #: 10Start Page: 978End Page: 989Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0Citation Count: 40
-
OPENTitle: Quantitative phosphoproteomics uncovers dysregulated kinase networks in Alzheimer’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 6Start Page: 550End Page: 565Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00071-1Citation Count: 37
-
RESTRICTEDTitle: Dysregulated miRNAs mark Parkinson’s disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2Citation Count: 1